Current Knowledge and Attitudes Concerning Cost-Effectiveness in Glaucoma Pharmacotherapy: A Glaucoma Specialists Focus Group Study.

Clin Ophthalmol · 2020 · PMC7064281 · PMID 32184559

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

fairly significantno p-value reported

33 An incremental improvement in efficacy, such as that reported with LBN, could be fairly significant from the cost-effectiveness standpoint.

also in 581 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.